Army I know your post was deleted, but here's my

New Post Public Reply Private Reply Replies (1) Message Board
Notaguru
632
Army I know your post was deleted, but here's my reply.

If Doc is for real and actually has the goods and the ability to get us out of penny land, maybe Nasdaq then he won't be taken down. The truth and the reasons for the "delays" will come out. If he doesn't have anything and it's a scam, I think we all agree, Doc needs taken down and jail time.

Despite Doc's lies and misleading statements, I own shares for 1 main reason. FOMO...the fear of missing out. However bad, things have been looking, which I think you will agree with by the tone of your posts, anything is possible. I've said many times that I still own all my shares. I'm torn between knowing he has lied and misled and wondering why in the hell he would lie and mislead at his age, knowing it would all blow up. He knows there are people like Toodles, and you who won't just sit and be lied to forever. He will be exposed. You said what needed said on the other board, and Toodles has posted many facts, which he has backed up on this board.

I am elated for all that the share price has moved up. I feel bad for those who had to sell. Some will see this as a selling opportunity and if it gets them in the black, I'm happy for them. Unlike MLR, I won't laugh at them if we move way up, I'll feel bad that after years of waiting on and being lied to by Doc, they made the difficult decision to sell before Doc finally came through....if he ever comes through. Many long time supporters of Doc have given up and moved on. He can't cry wolf but so many times. We all will agree it's ridiculous for him to say what he has and still be where we are. Many friendships and family member relationships have been ruined over this. If Doc wasn't ready to launch then don't freaking say so. I've said before, if this was some dark penny stock with little info and you lost money, that's gambling, but when the CEO states we will uplist in Q1 2021 and we're still at a penny, we'll there's no excuse.

Hope everyone has a nice day
1
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dario's Personify Panel Puts Distribution Model in Focus

Updated Category News Views 246

A Partner Megaphone Is Not a Revenue Line Monday's virtual panel gives DarioHealth a useful stage, but investors should not confuse a conference microphone with a signed sales order. Erez Raphael is set to lead a November 23 discussion with Personify Health President Ed Liebowitz at the U.S. Bancorp | BTIG Tech-Enabled Healthcare Forum, running from noon to 12:50 p.m....

Continue Reading
Fervo IPO Lawsuit Puts 71% Share Collapse in Focus

Updated Category News Views 53

Fervo’s $27 debut has turned into the sort of wreckage IPO buyers dread: shares were alleged to have closed as low as $7.79 when the complaint was filed. That is more than a 71% fall from the May 13, 2026 offering price, and it puts a hard, ugly number beside the new securities class action against the geothermal power developer. More Than a Bad Quarter Is Being Alleged...

Continue Reading
Align Wagner Collection Tests Men's Footwear Depth

Updated Category News Views 57

Three pairs of shoes are not a revolution, but they can expose whether a young brand has its footing. Align, established in 2025 by H.H. Brown, is rolling out the Wagner collection for Fall-Winter 2026 with a waterproof boot, a penny loafer and a lace-up oxford. That is a sensible little arsenal, not some overstuffed catalog dreamed up by a marketing committee that has...

Continue Reading
Tigerlily Brings HIV Information to Women’s Health

Updated Category News Views 60

A stubborn information gap is exactly where Tigerlily Foundation is planting its flag. The nonprofit’s new national HIV education and awareness campaign, THE POWER OF U, expands work that began in breast cancer advocacy into another area where women need clear facts, trusted voices, and room to speak without being shamed for needing answers. This is not a story that...

Continue Reading
PayPal's New Leadership Map Puts Execution on Trial

Updated Category News Views 106

Four senior appointments and a risk-chief exit can turn a tidy strategy slide into a very real operating test. PayPal has spent months defining three-year plans, simplifying its operating model and assigning clearer accountability; on November 20, it put names beside the jobs. For NASDAQ:PYPL investors, that is more consequential than another broad promise about...

Continue Reading
TCL CSOT's Oxide Leap Gives LCD a Sharper Fight Ahead

Updated Category News Views 73

Fifty-one point six is the number that makes this announcement worth chewing on. TCL CSOT says it has moved ultrahigh-mobility oxide technology into mass production on an 8.6-generation line, clearing the 50 cm² V?¹ s?¹ threshold that has largely belonged to lab-talk and presentation slides. For display people, that is not decorative science. It could change the old...

Continue Reading
OU's $44.3M Rural Care Plan Targets Oklahoma Care Gaps

Updated Category News Views 70

A Long Drive Is a Brutal Barrier to Care Seventy-five of Oklahoma's 77 counties sit in health professional shortage territory, a figure that ought to stop people cold. It means at least 3,500 patients per provider in those counties. That is not some abstract planning headache. It is the pregnant patient delaying a specialist visit, the family weighing an ambulance ride,...

Continue Reading
Surfcomber Uses Art Week to Deepen Its Guest Appeal

Updated Category News Views 77

Miami Art Week can turn every hotel lobby into a billboard, but Surfcomber is at least trying to make its walls do some actual work. Kimpton Surfcomber Hotel is spreading local artists, participatory events, food, cocktails and retail across the property rather than hanging a few paintings and calling it culture. For a South Beach hotel with 200 feet of oceanfront, that...

Continue Reading
PPL's January Dividend Keeps Utility Appeal Intact

Updated Category News Views 125

A dividend notice is rarely thrilling, but it can still separate a steady utility from a story stock peddling fumes. PPL Corporation declared a quarterly common dividend of $0.2850 per share on Nov. 20, payable Jan. 4, 2027. Shareholders must be on the books by Dec. 10, 2026, to receive it. Plain vanilla stuff, yes. Still, plain vanilla is often precisely why utility...

Continue Reading
University of Phoenix Poll Gets a Useful Reality Check

Updated Category News Views 89

Good Numbers, With the Usual Fine Print Employer approval is the kind of evidence career-focused schools desperately need, and University of Phoenix just put up a pretty loud batch of it. Among managers who directly supervise its graduates, 94% said the university understands employer needs, while 92% said its programs align with workforce demands. Those are stout...

Continue Reading

Top 5 Most Recently Viewed Articles

Important Update for Sable Offshore Investors on Class Action

Updated Category News Views 261

Important Update for Sable Offshore Investors Sable Offshore Corp. (SOC), a prominent player in the oil transportation industry, is currently entangled in legal proceedings that have implications for its investors. If you've invested in SOC and suffered losses exceeding $100,000, there are critical updates you need to be aware of. Details on the Class Action Lawsuit A...

Continue Reading
Polestar Automotive Faces Lawsuit Over Financial Discrepancies

Updated Category News Views 353

Overview of the Legal Situation Concerning Polestar Automotive Recent events have brought attention to Polestar Automotive Holding UK PLC (NASDAQ: PSNY), a company known for its electric vehicles. A securities class action lawsuit has emerged, filed in the United States District Court for the District of New Jersey. This legal action is essential for individuals who...

Continue Reading
Quest Diagnostics' Q3 2024 Performance Boosts Annual Outlook

Updated Category News Views 257

Quest Diagnostics Reports Impressive Q3 2024 Financial Results Quest Diagnostics Incorporated (NYSE: DGX), a top provider of diagnostic information services, has shared its encouraging financial performance for the third quarter ended September 30, 2024. The company saw a notable increase in revenues, reaching $2.49 billion, representing an 8.5% rise compared to the...

Continue Reading
Castle Biosciences Receives NY Health Approval for TissueCypher

Updated Category News Views 118

Castle Biosciences Gains Approval for Revolutionary Test Castle Biosciences, Inc. (NASDAQ: CSTL), based in Friendswood, Texas, is charting a transformative course in healthcare with its recent approval from the New York State Department of Health for its TissueCypher Barrett’s Esophagus test. This achievement marks a significant milestone as TissueCypher stands out as...

Continue Reading
Oryzon Genomics to Conduct Insightful Virtual KOL Event

Updated Category News Views 147

Oryzon Genomics to Host Virtual KOL Event Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), renowned for its innovations in the field of epigenetics, has announced an engaging virtual KOL event aimed at addressing the complexities of Borderline Personality Disorder (BPD). This event, scheduled for a Wednesday at 12:00 pm ET, will be expertly moderated by Dr. Michael...

Continue Reading